Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services)
$59.48
neg -0.50
-0.83%
Today's Range: 59.12 - 60.29 | DGX Avg Daily Volume: 2,576,600
Last Update: 04/17/14 - 4:05 PM EDT
Volume: 1,481,955
YTD Performance: 11.08%
Open: $59.98
Previous Close: $59.98
52 Week Range: $50.46 - $64.10
Oustanding Shares: 144,307,147
Market Cap: 8,652,889,342
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 11 12 12 11
Moderate Sell 1 1 1 1
Strong Sell 3 3 3 2
Mean Rec. 3.14 3.13 3.13 2.90
Latest Dividend: 0.33
Latest Dividend Yield: 2.39%
Dividend Ex-Date: 04/04/14
Price Earnings Ratio: 10.39
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
10.39 10.80 29.01
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.76% 3.68% 1.90%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.20 -0.03 -0.01
Net Income 49.10 0.12 0.04
EPS 60.60 0.37 0.11
Earnings for DGX:
EBITDA 1.32B
Revenue 7.15B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.89 $1.08 $4.04 $4.32
Number of Analysts 13 13 14 13
High Estimate $0.98 $1.13 $4.16 $4.61
Low Estimate $0.77 $1.05 $3.93 $3.92
Prior Year $0.89 $1.06 $4.00 $4.04
Growth Rate (Year over Year) -0.09% 1.74% 1.00% 7.01%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Apr 14, 2014 | 8:19 AM EDT
Shares of DGX now seen reaching $62, according to Credit Suisse. Estimates also upped, given better reimbursement trends and the Solsta...
Update
Feb 25, 2014 | 7:12 AM EST
RBC Capital Markets Healthcare Conference
Bearish
Jan 31, 2014 | 8:10 AM EST
DGX cut its numbers, UBS said. 1Q14 expected to be impacted by sequestration and weather. $56 price target and Neutral rating. 
Quest Diagnostics -- and others in this beaten-down sector -- are excellent trading vehicles.
Bearish
Dec 10, 2013 | 7:23 AM EST
DGX was downgraded to Underperform, Bank of America/Merrill Lynch said. $55 price target. Expect weak growth and pricing prospects to c...
Bullish
Aug 08, 2013 | 7:59 AM EDT
DGX was upgraded from Hold to Buy, Maxim Group said. $73 price target. New management team is cutting costs and working to restore grow...
Bullish
Jul 19, 2013 | 8:09 AM EDT
DGX estimates were raised on increased buybacks, said UBS. Price target increased to $61.
Update
Jul 12, 2013 | 7:16 AM EDT
DGX was initiated with a Neutral rating, Robert Baird said. $58 price target. Turnaround story may still take some time.   
Bearish
Jul 09, 2013 | 7:47 AM EDT
Shares of DGX were downgraded to Underweight from Equal-weight, said Morgan Stanley. Price target is $58. Cuts to physician fee schedul...
Update
Jun 06, 2013 | 7:19 AM EDT
Jefferies Global Healthcare Conference (Day 4 of 4) - 06/03/13 - 06/06/13 New York City, NY

Columnist Conversations

There were nice reversal-type candles on the weekly charts of the major indices. The DOW and the S&P forme...
A number of stocks on my watch lists are attempting to form positive candles a key support levels. I noted th...
Lang:
While last week was a day to pull the plug and contemplate where the market was headed, I waited for some conf...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: the September head an...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.